explore -WSS

explore

author：Wikipedia 2025-10-01 00:59:02 - browse：24531

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs.

It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA. The biotech hired rapidly, announced its intention to treat a broad range of diseases, and received clearance to start clinical trials in cancer and sickle cell.

Beam, however, has struggled to enroll patients in those trials. Meanwhile, the biotech stock market has stayed cold, including for gene-editing companies, whose technologies raise new regulatory, safety, and reimbursement questions. The pending approval of two gene therapies for sickle cell would also limit the market for Beam’s lead drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Baltimore teen accused of firing into crowd during block party mass shooting

entertainment

WSS

Affordable Connectivity Program vital to health care, experts say

Affordable Connectivity Program vital to health care, experts say

Study identifies new proteins linked to dementia risk 25 years later

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Beware the threat of staffing cuts at the CDC

Stanford president's case begs question: Who takes blame?

Wikipedia

explore

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Divers poised to search for children washed away in Pennsylvania flash flood

Guidelines to prevent youth baseball injuries need more muscle

EF3 tornado rips through North Carolina amid extreme weather nationwide

Dobbs anniversary: the lost opportunity of abortion as health care

As Maui death toll rises, number of missing remains unclear

Supreme Court strikes down use of affirmative action

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Medical records are filled with copy

I learned firsthand about improving diversity in clinical trials

entertainment

Evacuations in place as 3 wildfires burn in eastern Washington state

New details revealed about Purdue's marketing of OxyContin

New details revealed about Purdue's marketing of OxyContin

DeSantis talks Trump, trans issues and 'what wokeness is'

Ending racial health disparities hinges on penalties, political will

Majority of Americans think Trump's Ga. election interference case is serious: POLL

knowledge

explore

entertainment

focus